Literature DB >> 7680511

A simplified assay for the specific diagnosis of paroxysmal nocturnal hemoglobinuria: detection of DAF(CD55)- and HRF20(CD59)- erythrocytes in microtyping cards.

B Nilsson1, U Hagström, A Englund, J Säfwenberg.   

Abstract

Paroxysmal nocturnal hemoglobinuria (PNH) is a rare disease that is caused by a monoclonal stem cell defect. The affected cells lack the carbohydrate linkage between phosphatidylinositol and a group of membrane proteins of which three protect the cell against complement lysis. The absence of these three proteins, DAF(CD55), C8BP and HRF20(CD59), makes cells from the erythropoiesis, thrombopoiesis and myelopoiesis extensively sensitive to complement attack and affected patients suffer from intravascular hemolysis, thrombosis and increased susceptibility to infections. In this study we describe a swift and specific assay for the detection of CD55- and CD59- erythrocytes, which is suitable for screening of possible PNH patients.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7680511     DOI: 10.1111/j.1423-0410.1993.tb02513.x

Source DB:  PubMed          Journal:  Vox Sang        ISSN: 0042-9007            Impact factor:   2.144


  2 in total

1.  Detection of CD55- and/or CD59-deficient red cell populations in patients with plasma cell dyscrasias.

Authors:  John Meletis; Evangelos Terpos; Michalis Samarkos; Christos Meletis; Effie Apostolidou; Veroniki Komninaka; Konstantinos Korovesis; Konstantinos Anargyrou; Olga Benopoulou; Despina Mavrogianni; Eleni Variami; Nora Viniou; Konstantinos Konstantopoulos
Journal:  Int J Hematol       Date:  2002-01       Impact factor: 2.490

2.  Eculizumab, a terminal complement inhibitor, improves anaemia in patients with paroxysmal nocturnal haemoglobinuria.

Authors:  Jörg Schubert; Peter Hillmen; Alexander Röth; Neal S Young; Modupe O Elebute; Jeffrey Szer; Giacomo Gianfaldoni; Gérard Socié; Paul Browne; Robert Geller; Russell P Rother; Petra Muus
Journal:  Br J Haematol       Date:  2008-05-22       Impact factor: 6.998

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.